OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S52-S76
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 3

Metabolic Dysfunction–Associated Steatotic Liver Disease
Sajjadh M. J. Ali, Michelle Lai
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 1

Hypoglycemia knowledge assessment tool — Development and validation of the Hypoglycemia Management Knowledge Scale in Taiwan
Mei‐Chuan Huang, Hua‐Tsen Hsiao, Ya‐Ping Yang, et al.
Applied Nursing Research (2025), pp. 151916-151916
Closed Access | Times Cited: 1

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
Eric Lawitz, Mandy Fraessdorf, Guy Neff, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 837-846
Open Access | Times Cited: 12

Diabetes Management in Detention Facilities: A Statement of the American Diabetes Association
Daniel L. Lorber, Nuha A. ElSayed, Raveendhara R. Bannuru, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 544-555
Open Access | Times Cited: 9

No More NAFLD: The Term Is Now MASLD
Ji Cheol Bae
Endocrinology and Metabolism (2024) Vol. 39, Iss. 1, pp. 92-94
Open Access | Times Cited: 6

Type 2 Diabetes
Allison L. Crawford, Neda Laiteerapong
Annals of Internal Medicine (2024) Vol. 177, Iss. 6, pp. ITC81-ITC96
Closed Access | Times Cited: 6

Strategies to Overcome Metabolic Syndrome and Related Diseases

Frontiers research topics (2025)
Closed Access

Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy
Sara de Lope Quiñones, Manuel Luque‐Ramírez, Antonio Michael-Fernández, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 55-55
Open Access

Addressing Diabetes Distress in Primary Care: Where Are We Now, and Where Do We Need to Go?
Marisa Kostiuk, Erik Seth Kramer, Andrea Nederveld, et al.
Current Diabetes Reports (2025) Vol. 25, Iss. 1
Closed Access

Role of Immunization in Adults with Diabetes in India: An Overview
Mayura Kale, Banshi Saboo, Aniket Inamdar, et al.
Chronicle of Diabetes Research and Practice (2025) Vol. 4, Iss. 1, pp. 42-48
Closed Access

Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations
Christina Brock, Henning Andersen, Amra Ciric Alibegovic, et al.
Diabetes Research and Clinical Practice (2025), pp. 112010-112010
Open Access

Geospatial analysis and determinant factors of comorbidity presence in patients with diabetes in Peru
Víctor Juan Vera-Ponce, Fiorella E. Zuzunaga-Montoya, Luisa Erika Milagros Vásquez-Romero, et al.
Endocrine and Metabolic Science (2025), pp. 100222-100222
Open Access

Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Åke Sjöholm, Louise Bennet, Peter M. Nilsson
Scandinavian Journal of Primary Health Care (2025), pp. 1-7
Open Access

Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes
Jillian Fetzner, Ebne Rafi
The Journal of Clinical Endocrinology & Metabolism (2025) Vol. 110, Iss. Supplement_2, pp. S147-S158
Closed Access

Fragilità ossea nel diabete: meccanismi fisiopatologici e strategie terapeutiche
Viola Viola, Malak Faraj, Francesca Cannata, et al.
L Endocrinologo (2025)
Closed Access

Physical Fitness and Activity Levels as Predictors of Subjective Well‐Being in Youths With Type 1 Diabetes Mellitus: A 2‐Year Longitudinal Analysis of the Diactive‐1 Cohort Study
Jacinto Muñoz-Pardeza, José Francisco López‐Gil, Nidia Huerta‐Uribe, et al.
Scandinavian Journal of Medicine and Science in Sports (2025) Vol. 35, Iss. 3
Closed Access

Risk of Serious Bacterial and Non‐Bacterial Infections in People With MASLD
Giovanni Targher, Herbert Tilg, Luca Valenti
Liver International (2025) Vol. 45, Iss. 4
Open Access

Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting
Alina M. Allen, Michael Charlton, Kenneth Cusi, et al.
Postgraduate Medicine (2024) Vol. 136, Iss. 3, pp. 229-245
Open Access | Times Cited: 4

A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
Lindsay T. Fourman, Josivan Gomes Lima, Vinaya Simha, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4

Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease
Anne‐Sofie H. Jensen, Henriette Ytting, Mikkel Werge, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 6, pp. G736-G746
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top